{"id":"CHEMBL1093","canonicalSmiles":"CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC","inchiKey":"QTGIAADRBBLJGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTICAINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["40 045","40-045","Articaine","Carticaine","HOE 045","HOE-045","Septocaine"],"crossReferences":{"DailyMed":["articaine%20hydrochloride"],"Wikipedia":["Articaine"],"drugbank":["DB09009"]},"childChemblIds":["CHEMBL1200819"],"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_1001139","EFO_1001216","EFO_0000649","EFO_0003843","EFO_1002048"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 investigational indications."}
{"id":"CHEMBL1095283","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccccc3)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"NZDASSHFKWDBBU-KVMCETHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN PHENYL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carfecillin"],"crossReferences":{"Wikipedia":["Carfecillin"],"drugbank":["DB13506"],"chEBI":["3414"]},"childChemblIds":["CHEMBL2105996"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1102","canonicalSmiles":"CCC1(c2ccccc2)CCC(=O)NC1=O","inchiKey":"JMBQKKAJIKAWKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTETHIMIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doriden","Glutethimide"],"synonyms":["Elrodorm","Glutethimide","NSC-95239","Noxyron","Rigenox","Sarodormin"],"crossReferences":{"PubChem":["144205194","170465223","29215340"],"Wikipedia":["Glutethimide"],"drugbank":["DB01437"],"chEBI":["5439"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL112322","canonicalSmiles":"CN(C)c1ccc(C(=O)O)cc1","inchiKey":"YDIYEOMDOWUDTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Dimethylamino-Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Dimethylamino-Benzoic Acid"],"crossReferences":{"drugbank":["DB08748"]},"childChemblIds":["CHEMBL1762663"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL114","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1","inchiKey":"QWAXKHKRTORLEM-UGJKXSETSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SAQUINAVIR","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortovase","Invirase"],"synonyms":["Invirase","RO 31-8959/000","Ro-31-8959","SCH-52852","Saquinavir","Saquinavirum"],"crossReferences":{"DailyMed":["saquinavir%20mesylate"],"PubChem":["49666064","50105601"],"Wikipedia":["Saquinavir"],"drugbank":["DB01232"],"chEBI":["63621"]},"childChemblIds":["CHEMBL282042"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1153","canonicalSmiles":"C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O","inchiKey":"SHIBSTMRCDJXLN-KCZCNTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGOXIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124882990","251919877","26754265","56463065"],"Wikipedia":["Digoxigenin"],"drugbank":["DB03671"],"chEBI":["42098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200419","canonicalSmiles":"CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl","inchiKey":"GQWNECFJGBQMBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOLINDONE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL460","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moban","Molindone hydrochloride"],"synonyms":["EN-1733A","Molindone hcl","Molindone hydrochloride"],"crossReferences":{"DailyMed":["molindone%20hydrochloride"],"PubChem":["144204130","170465047","26753596","49648854"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for schizophrenia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200444","canonicalSmiles":"CC(=O)O.CC(C)(C)NCC(O)c1ccc(O)c(CO)n1","inchiKey":"QSXMZJGGEWYVCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRBUTEROL ACETATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1094966","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxair"],"synonyms":["CP-24,314-14","CP-24314-14","Pirbuterol acetate","Pirbuterol monoacetate","Spirolair"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for asthma."}
{"id":"CHEMBL1200487","canonicalSmiles":"C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl.[Na+]","inchiKey":"CWCSCNSKBSCYCS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHACRYNATE SODIUM","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edecrin","Ethacrynate sodium"],"synonyms":["Etacrynate sodium","Ethacrynate sodium","Ethacrynic acid sodium salt","Sodium etacrynate","Sodium ethacrynate"],"crossReferences":{"DailyMed":["ethacrynate%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL1200699","canonicalSmiles":"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O","inchiKey":"XQTWDDCIUJNLTR-CVHRZJFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doxychel","Doxycycline","Monodox","Oracea","Vibramycin"],"synonyms":["Doxirobe","Doxycycline","Doxycycline monohydrate","Doxylin","GS-3065","Supracyclin","Xyrosa"],"crossReferences":{"DailyMed":["doxycycline"],"chEBI":["60648"]},"linkedTargets":{"rows":["ENSG00000196611","ENSG00000137745","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000842","EFO_0000365","EFO_0007486","EFO_0000756","EFO_0009536","EFO_0007272","EFO_0005952","EFO_0003102","Orphanet_85443","EFO_1001951","EFO_0007205","EFO_0000771","EFO_1001459","EFO_0000096","EFO_0000544","EFO_0007357","EFO_1000961","EFO_0008517","EFO_1000785","MONDO_0002635","EFO_0002618","EFO_1001235","EFO_0007504","EFO_0002687","EFO_1000906","HP_0000964","MONDO_0022113","EFO_1001466","Orphanet_3389","EFO_0000662","Orphanet_558","EFO_0000384","EFO_0003878","EFO_1001444","EFO_1000760","EFO_1001388","MP_0001914","EFO_0007460","MONDO_0100096","EFO_0007430","HP_0000130","DOID_7551","EFO_1001177","EFO_0000574","EFO_0009659","EFO_1001051","EFO_0000341","EFO_1001312","Orphanet_314701","EFO_0009637","EFO_0004214","EFO_0001365","EFO_1001984","EFO_0009117","EFO_0000768","EFO_0002913","Orphanet_586","EFO_0011048","EFO_0000274","Orphanet_85451","EFO_0005622","EFO_0009425","EFO_0008510","HP_0002013","EFO_0000778","EFO_1001788","HP_0001945","EFO_1001875","EFO_0003770","EFO_0000319","Orphanet_271861","HP_0001250","EFO_0003894","EFO_1002047","EFO_1000941","EFO_0003060","EFO_0003843","EFO_0000311","EFO_0003106","MONDO_0005301","EFO_0001068","EFO_0000649","EFO_0000764","MONDO_0004975","EFO_0000199","EFO_1000781","EFO_0000612","EFO_0007410","MONDO_0043510","EFO_0007185","EFO_0001067","MONDO_0024880","MONDO_0005178","EFO_0007480","EFO_0003895"],"count":96},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 15 approved and 56 investigational indications."}
{"id":"CHEMBL1200982","canonicalSmiles":"CCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]","inchiKey":"QORQZMBCPRBCAB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTABARBITAL SODIUM","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL449","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Butabarb","Butabarbital","Butabarbital sodium","Butalan","Buticaps","Butisol sodium","Sarisol","Sarisol no. 1","Sarisol no. 2","Sodium butabarbital"],"synonyms":["Astrudion","Butabarbital sodium","Butabarbital sodium salt","Loubarb","Mebutal","NSC-11778","Secbutabarbital sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939."}
{"id":"CHEMBL1201149","canonicalSmiles":"Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"RHBRMCOKKKZVRY-ITLPAZOVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NALTREXONE HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL19019","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adepend","Depade","Nalorex","Naltrexone hydrochloride","Opizone","Revia"],"synonyms":["EN-1639A","EN-1639A (AS HYDROCHLORIDE)","Naltrexone hcl","Naltrexone hydrochloride","Trexan"],"crossReferences":{"DailyMed":["naltrexone%20hydrochloride"],"PubChem":["56422210","855955"]},"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["Orphanet_166","EFO_0005203","MONDO_0100096","HP_0012532","EFO_0005611","EFO_0004701","HP_0100716","EFO_0010702","EFO_0003843"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201264","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21","inchiKey":"GZHFODJQISUKAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANTHELINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methantheline","Methantheline cation","Methantheline ion","Methanthelinium"],"crossReferences":{"PubChem":["11112123"],"Wikipedia":["Methantheline"],"drugbank":["DB00940"],"chEBI":["6817"]},"childChemblIds":["CHEMBL1200988"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","HP_0000011"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL1201317","canonicalSmiles":"O=P(O)(O)OCC(Cl)(Cl)Cl","inchiKey":"YYQRGCZGSFRBAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOFOS","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Neguvon","Tri-beta-chloroethylphosphate","Triclofos"],"crossReferences":{"Wikipedia":["Triclofos"],"drugbank":["DB06753"],"chEBI":["9695"]},"childChemblIds":["CHEMBL1200789"],"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000182256","ENSG00000102287","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0003758"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201326","canonicalSmiles":"[Rb]","inchiKey":"IGLNJRXAVVLDKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBIDIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rubidium"],"crossReferences":{"drugbank":["DB11346"],"chEBI":["33322"]},"childChemblIds":["CHEMBL4297424"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1230016","canonicalSmiles":"CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"XFNMDMGNNKIXBT-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230016","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06996"]},"childChemblIds":["CHEMBL3423208"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231350","canonicalSmiles":"O=C(O)c1cc2cc(O)ccc2cc1O","inchiKey":"QMWOUSYSNFCKAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231350","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231913","canonicalSmiles":"Clc1ccc(-c2cnc[nH]2)cc1","inchiKey":"DVKIFCXVRCGAEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231913","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232243","canonicalSmiles":"O=C(O)c1cc(I)cc(I)c1O","inchiKey":"DHZVWQPHNWDCFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232243","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04674"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233239","canonicalSmiles":"CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(cc2)OCCCC(=O)N[C@@H](CC(N)=O)C(=O)N1)S(=O)(=O)c1ccccc1","inchiKey":"HOUHLOFMBSYNBO-KKUQBAQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233239","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02411"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234578","canonicalSmiles":"Nc1cccc2cc(S(=O)(=O)O)ccc12","inchiKey":"UWPJYQYRSWYIGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234578","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89853209"],"drugbank":["DB08238"],"chEBI":["44188"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235136","canonicalSmiles":"O=C(NO)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"OHQFMJPEBPCIEQ-JJYYJPOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235136","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256723","canonicalSmiles":"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl","inchiKey":"RUYHIJHUVHIMIR-CVHRZJFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doxycycline hcl","Doxycycline hydrochloride","NSC-756751"],"crossReferences":{"PubChem":["144204117","170465097"],"chEBI":["652992"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1269102","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O","inchiKey":"VYCMAAOURFJIHD-AOYLRGCGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BQ-123","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BQ-123","BQ123","Bq-123","Cyclo(d-trp-d-asp-pro-d-val-leu)"],"crossReferences":{"Wikipedia":["BQ-123"]},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL12856","canonicalSmiles":"Nc1cc(-c2ccncc2)c[nH]c1=O","inchiKey":"RNLQIBCLLYYYFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INAMRINONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inocor"],"synonyms":["Amcoral","Amrinone","C01CE01","Cartonic","Cordemcura","Inamrinone","NSC-759805","Vesistol","WIN 40680","WIN-40680","Wincoram"],"crossReferences":{"PubChem":["11112811","11533005","124882647","144205663","144212164","170465367","26750001","26757798","56424028"],"Wikipedia":["Amrinone"],"drugbank":["DB01427"]},"childChemblIds":["CHEMBL2096642"],"linkedTargets":{"rows":["ENSG00000172572"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1396177","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"BBTOYUUSUQNIIY-ANPZCEIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN V BENZATHINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL615","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzathine penicillin v","Benzathine phenoxymethylpenicillin","Penicillin benzathine phenoxymethyl","Penicillin v benzathine"],"crossReferences":{"DrugCentral":["4440"],"PubChem":["11112967"],"chEBI":["31973"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1519","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21","inchiKey":"VXFJYXUZANRPDJ-WTNASJBWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRANDOLAPRIL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gopten","Mavik","Odrik","Trandolapril"],"synonyms":["Indolapril","NSC-758939","RU 44570","RU-44570","Trandolapril"],"crossReferences":{"DailyMed":["trandolapril"],"PubChem":["144205006","144206703","90340949"],"Wikipedia":["Trandolapril"],"drugbank":["DB00519"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000319","EFO_0000612","EFO_0000266","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1615025","canonicalSmiles":"Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21","inchiKey":"RCLQNICOARASSR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-733","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mek inhibitor tak-733","TAK-733","TAK733","Tak 733","Tak-733"],"crossReferences":{"drugbank":["DB12241"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002617","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL16502","canonicalSmiles":"CC(C)(C)O","inchiKey":"DKGAVHZHDRPRBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERT-BUTANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Tert-Butyl_alcohol"],"drugbank":["DB03900"],"chEBI":["45895"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1650317","canonicalSmiles":"CCC(C)(C)C(=O)[O-].[Na+]","inchiKey":"OOPXYEYPPHJHSE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM 2,2-DIMETHYLBUTYRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL286013","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HQK-1001","Hqk-1001","Sodium 2,2 dimethylbutyrate","Sodium 2,2-dimethylbutyrate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1689772","canonicalSmiles":"CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"JEECQCWWSTZDCK-IQZGDKDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMADACYCLINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amadacycline","BAY 73-6944","Omadacycline","PTK 0796"],"crossReferences":{"DailyMed":["omadacycline%20tosylate"],"drugbank":["DB12455"]},"childChemblIds":["CHEMBL3942449","CHEMBL3954447","CHEMBL2103854"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL1735","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O.O=S(=O)(O)O","inchiKey":"NUBQKPWHXMGDLP-BDEHJDMKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDINAVIR SULFATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL115","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crixivan"],"synonyms":["Crixivan","Indinavir sulfate","Indinavir sulfate ethanolate","Indinavir sulphate","Indinaviri sulfas","L-735,524","L-735524","MK-639","NSC-697197"],"crossReferences":{"DailyMed":["indinavir%20sulfate"],"PubChem":["144205240","144212732","170465228","49681566"],"chEBI":["5899"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for hiv infection and has 6 investigational indications."}
{"id":"CHEMBL1788132","canonicalSmiles":"CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl","inchiKey":"DWWHMKBNNNZGHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFEXIDINE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL17860","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Britlofex","Lofexidine","Lucemyra"],"synonyms":["Lofexidine hcl","Lofexidine hydrochloride","MDL 14,042","MDL-14042","NSC-759654"],"crossReferences":{"DailyMed":["lofexidine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0005800","EFO_0005611"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for substance withdrawal syndrome and has 1 investigational indication."}
{"id":"CHEMBL1797128","canonicalSmiles":"C[S+](C)CC[C@H](N)C(=O)O.[Cl-]","inchiKey":"MYGVPKMVGSXPCQ-JEDNCBNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLMETHIONINE SULFONIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL45024","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methiosulfonium chloride","Methylmethionine sulfonium chloride","Vitamin U"],"crossReferences":{"drugbank":["DB13250"],"chEBI":["6884"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL185918","canonicalSmiles":"Oc1ccc2nc(-c3cccc4c(O)cccc34)oc2c1","inchiKey":"JHOZVRGNIYFYHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185918","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1870768","canonicalSmiles":"CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"SWECWXGUJQLXJF-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHINDENE MALEATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL22108","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fenostil","Forhistal maleate"],"synonyms":["Dimethindene maleate","Dimethpyrindene maleate","Dimetindene maleate","NSC-107677","SU-6518"],"crossReferences":{"PubChem":["92764835"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1980535","canonicalSmiles":"CC(=O)O[C@H]1CC(C)(C)C(=C=C/C(C)=C/C=C/C=C/C=C(C)/C=C2/C=C(/C=C/[C@@]34O[C@]3(C)C[C@@H](O)CC4(C)C)C(=O)O2)[C@](C)(O)C1","inchiKey":"UYRDHEJRPVSJFM-VSWVFQEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1980535","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["518143"],"drugbank":["DB03001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028850","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O","inchiKey":"QURWXBZNHXJZBE-SKXRKSCCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ICATIBANT","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["HOE-140","Icatibant"],"crossReferences":{"DailyMed":["icatibant%20acetate"],"drugbank":["DB06196"]},"childChemblIds":["CHEMBL2028852"],"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["Orphanet_68380","MP_0001845","MONDO_0100096","EFO_0003144","EFO_1000999","EFO_0005532","Orphanet_91378"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for angioedema and hereditary angioedema and has 6 investigational indications."}
{"id":"CHEMBL2068841","canonicalSmiles":"O=[N+]([O-])c1nccn1CC(O)CF","inchiKey":"HIIJZYSUEJYLMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROMISONIDAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluoromisonidazole","Fmiso","KU-2210","NSC-292930","RO-07-0741","SR-1367"],"childChemblIds":["CHEMBL2037002"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104591","canonicalSmiles":"CC(CCN1CCOCC1)OC(=O)C1(c2ccccc2)CCOCC1","inchiKey":"RDEOYUSTRWNWLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEDRILATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fedrilate","Gotas binelli","UCB 3928","UCB-3928"],"crossReferences":{"drugbank":["DB13825"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105395","canonicalSmiles":"OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1","inchiKey":"LUMKNAVTFCDUIE-VHXPQNKSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OSPEMIFENE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Osphena","Senshio"],"synonyms":["(deaminohydroxy) toremifene","FC-1271","FC-1271A","Ospemifene","Tore iii"],"crossReferences":{"DailyMed":["ospemifene"],"Wikipedia":["Ospemifene"],"drugbank":["DB04938"],"chEBI":["73275"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0004714","EFO_0000512","EFO_1000096","HP_0030016","EFO_0003922"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105662","canonicalSmiles":"CS(=O)(=O)O.O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1","inchiKey":"QKVKOFVWUHNEBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOMITAPIDE MESYLATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL354541","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Juxtapid"],"synonyms":["AEGR-733","AEGR-733 MESYLATE","Aegr-733 mesilate","BMS-201038","BMS-201038-04","Lomitapide mesilate","Lomitapide mesylate"],"crossReferences":{"DailyMed":["lomitapide%20mesylate"],"chEBI":["72299"]},"linkedTargets":{"rows":["ENSG00000138823"],"count":1},"linkedDiseases":{"rows":["HP_0003124","MONDO_0021187","Orphanet_391665","EFO_0004911"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105694","canonicalSmiles":"COCC(=O)[C@@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","inchiKey":"JVBGZFRPTRKSBB-MJBQOYBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELAPRISTONE ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Proellex","Proellextm","Progenta"],"synonyms":["CDB-4124","RU 44675","RU-44675","Telapristone acetate","ZPV-200"],"crossReferences":{"drugbank":["DB05253"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0010269","EFO_0000731","EFO_0001065","EFO_0001421","MONDO_0007254"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2105704","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O","inchiKey":"HWLFIUUAYLEFCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENVATINIB MESYLATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1289601","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lenvima"],"synonyms":["E-7080 MESYLATE","E7080","E7080 MESYLATE","Lenvatinib mesilate","Lenvatinib mesylate","Lenvatinib methanesulfonate"],"crossReferences":{"DailyMed":["lenvatinib%20mesylate"],"chEBI":["85995"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000489","EFO_1000592","MONDO_0002108","EFO_0002892","EFO_0000681","EFO_0002517","EFO_1000261","EFO_0003060","EFO_0005221","EFO_0002617","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL2106318","canonicalSmiles":"CNC(=O)c1c(I)c(NC(C)=O)c([125I])c(C(=O)[O-])c1[125I].[Na+]","inchiKey":"WCIMWHNSWLLELS-ZMWPDAOESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IOTHALAMATE SODIUM I 125","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201300","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glofil-125"],"synonyms":["Iodine (125i) sodium iotalamate","Iothalamate sodium i 125","Iothalamate sodium i-125","Iothalamate sodium i125","Iothalamate sodium, i-125","Sodium iotalamate (125 i)","Sodium iotalamate (125i)","Sodium iothalamate","Sodium iothalamate (125i)"],"crossReferences":{"DailyMed":["iothalamate%20sodium%20i-125"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107480","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTETATE INDIUM DISODIUM IN 111","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111129","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mpi indium dtpa in 111"],"synonyms":["Indium in-111 pentetate disodium","Pentetate indium disodium in 111","Pentetate indium disodium in-111","Pentetate indium disodium,in-111"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2107832","canonicalSmiles":"O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F","inchiKey":"VIUAUNHCRHHYNE-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Msc1936369a; as703026; emd 1036239"],"synonyms":["AS 703026","AS-703026","AS703026","As-703026","EMD 1036239","EMD-1036239","G-02443714","MSC-1936369A","MSC-1936369B","MSC1936369A","Msc-1936369","Pimasertib"],"crossReferences":{"drugbank":["DB14904"]},"childChemblIds":["CHEMBL4297676"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_1000044","EFO_0000389","MONDO_0008170","EFO_0000756","EFO_0000182","MONDO_0007254","EFO_0000222","EFO_0003060","EFO_1001951","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2108315","drugType":"Protein","blackBoxWarning":false,"name":"SOMATROPIN PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NNC-126-0083","NNC-1260083","NNC126-0083","Somatropin pegol"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108718","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SEMULOPARIN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-5026","Semuloparin sodium"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0004286","HP_0004936"],"count":2},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108795","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP C","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meningococcal polysaccharide vaccine group c","Meningococcus c, purified polysaccharides antigen conjugated"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109172","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGITALIS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Digifortis","Digiglusin"],"synonyms":["Digitalis","Digitalis leaf","Digitalis leaves","Digitalis purpurea","Digitalis purpurea leaf","Digitalis purpurea leaf extract","Digitalis purpurea whole","Digitalis, powdered","Digitalis,powdered","Foxglove leaf","Foxglove whole","Mao di huang leaf","Mao di huang whole","Purple foxglove leaf","Purple foxglove whole"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109266","drugType":"Antibody","blackBoxWarning":false,"name":"AVE-9633","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-9633","Ave-9633","HUMY9-6"],"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["MONDO_0004643"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109425","drugType":"Antibody","blackBoxWarning":false,"name":"14G2A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["14G2A","14g2a","Antibody 14g2a monoclonal"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109529","drugType":"Antibody","blackBoxWarning":false,"name":"MU-BC-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Angiomab"],"synonyms":["MU-BC-1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109584","drugType":"Antibody","blackBoxWarning":false,"name":"F16SIP 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F16SIP","F16sip 131i"],"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109585","drugType":"Antibody","blackBoxWarning":false,"name":"LY-2382770","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2382770","LY2382770","Ly-2382770"],"linkedTargets":{"rows":["ENSG00000105329"],"count":1},"linkedDiseases":{"rows":["EFO_0000401"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2360079","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"NUKVZKPNSKJGBK-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOPHENAZINE MALEATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1085","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tindal"],"synonyms":["Acephenazine dimaleate","Acetophenazine dimaleate","Acetophenazine maleate","NSC-169180","NSC-70600","SCH 6673","SCH-6673"],"crossReferences":{"PubChem":["144206283"],"chEBI":["2402"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL243978","canonicalSmiles":"c1cn(-c2ccc(Oc3nccc(Oc4ccc5c(c4)OCO5)n3)cc2)cn1","inchiKey":"XPXGYINSBORUMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243978","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL256528","canonicalSmiles":"C[C@H]1C[C@@H](C)CN(C(=O)c2cc(Br)ccc2NC(=O)CCC(=O)O)C1","inchiKey":"JSVSGWHGYIDZFX-TXEJJXNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL256528","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL271138","canonicalSmiles":"c1nc(N2CCOCC2)c2nc[nH]c2n1","inchiKey":"MEOMXKNIFWDDGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL271138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["7969883","862467"],"drugbank":["DB08780"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273453","canonicalSmiles":"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12","inchiKey":"PQSUYGKTWSAVDQ-ZVIOFETBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALDOSTERONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aldosterone","NSC-73856"],"crossReferences":{"PubChem":["26757653","56320630"],"Wikipedia":["Aldosterone"],"drugbank":["DB04630"],"chEBI":["27584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275446","canonicalSmiles":"C/N=C(\\S)NCCSCc1[nH]cnc1C","inchiKey":"FPBPLBWLMYGIQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metiamide","NSC-307755","SK&F 92058"],"crossReferences":{"Wikipedia":["Metiamide"],"drugbank":["DB08805"],"chEBI":["6896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279433","canonicalSmiles":"N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1","inchiKey":"JNUGFGAVPBYSHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-778123","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-778123"],"crossReferences":{"drugbank":["DB07227"]},"childChemblIds":["CHEMBL4297396"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL286939","canonicalSmiles":"N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O","inchiKey":"DCWXELXMIBXGTH-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL286939","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01962"],"chEBI":["37788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28721","canonicalSmiles":"O=C(O)C(S)C(S)C(=O)O","inchiKey":"ACTRVOBWPAIOHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Dimercapto-Succinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Dimercapto-Succinic Acid","2,3-Dimercaptosuccinic Acid","Meso-2,3-Dimercaptosuccinic Acid"],"crossReferences":{"PubChem":["49640648","57260145"],"drugbank":["DB14089"]},"childChemblIds":["CHEMBL1684992"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL304552","canonicalSmiles":"Oc1ccc([C@H]2Sc3cc(O)ccc3O[C@H]2c2ccc(OCCN3CCCCC3)cc2)cc1","inchiKey":"TWZNCTCQAGRUGQ-RRPNLBNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL304552","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03742"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186534","canonicalSmiles":"N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1","inchiKey":"WPEWQEMJFLWMLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVOCERANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apatinib","Apatinib free base","Rivoceranib","YN968D1","YN968D1 FREE BASE"],"crossReferences":{"PubChem":["124955476"],"drugbank":["DB14765"]},"childChemblIds":["CHEMBL3545414"],"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0000637","EFO_0011061","EFO_0000365","EFO_0000571","EFO_0000681","EFO_0000756","EFO_1001951","EFO_0000178","MONDO_0002974","MONDO_0008903","EFO_0000182","MONDO_0016784","EFO_0002618","EFO_0005922","EFO_0003893","EFO_1001956","MONDO_0002108","MONDO_0008170","EFO_0005842","EFO_1002017","EFO_0002939","EFO_1001968","MONDO_0008315","EFO_0005221","EFO_0009708","MONDO_0002691","EFO_0001061","MONDO_0000544","EFO_0003868","EFO_0005537","EFO_0004284","EFO_0000574","MONDO_0100342","MONDO_0007254","EFO_0001071","EFO_0004252","MONDO_0021063","EFO_0000708","EFO_0000231","MONDO_0001056","EFO_1001480","EFO_1000218","EFO_0003860","EFO_0000326","EFO_0000707","HP_0001541","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","EFO_0000503","Orphanet_59305","EFO_0000403","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000621","EFO_0000311","EFO_1001961","EFO_0000211","MONDO_0002120","EFO_0004142","EFO_0000702","EFO_0000199","MONDO_0003219","EFO_0000691","EFO_0000181"],"count":70},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 59 investigational indications."}
{"id":"CHEMBL33","canonicalSmiles":"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"GSDSWSVVBLHKDQ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOFLOXACIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evoxil","Floxacin","Iquix","Levaquin","Levofloxacin","Oftaquix","Quinsair","Quixin","Tavanic"],"synonyms":["Cravit","DR-3355","L-ofloxacin","Levofloxacin","Levofloxacin (as hemihydrate)","Levofloxacin anhydrous","Levofloxacin hemihydrate","Levofloxacin hydrate","NSC-758709","Nofaxin","Ofloxacin s-(-)-form","Ofloxacin s-(-)-form hemihydrate","Ofloxacin, (s)-","RWJ-25213","Volequin"],"crossReferences":{"DailyMed":["levofloxacin"],"PubChem":["26719895","49665952"],"Wikipedia":["Levofloxacin"],"drugbank":["DB01137"],"chEBI":["63598"]},"childChemblIds":["CHEMBL2237108"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 11 approved and 32 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL337612","canonicalSmiles":"O=C1CN2C(=O)CCC2N1","inchiKey":"XTXXOHPHLNROBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMIRACETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimiracetam","NT-11624"],"crossReferences":{"Wikipedia":["Dimiracetam"],"drugbank":["DB13018"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545156","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2450","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KW-2450","Kw-2450"],"linkedTargets":{"rows":["ENSG00000140443","ENSG00000171105"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545423","canonicalSmiles":"NC1CCCN(c2c(/C=C3/SC(=O)NC3=O)cccc2-c2ccccc2)C1","inchiKey":"MCUJKPPARUPFJM-LDADJPATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1208","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 1208","Azd-1208"],"linkedTargets":{"rows":["ENSG00000102096","ENSG00000137193","ENSG00000198355"],"count":3},"linkedDiseases":{"rows":["EFO_0000574","EFO_0000222","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3549142","canonicalSmiles":"NC[C@H]1OB(O)c2c(OCCCO)cccc21","inchiKey":"FXQIIDINBDJDKL-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPETRABOROLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AN-3365","AN3365","An3365","Epetraborole","GSK-2251052","GSK2251052","Gsk2251052"],"crossReferences":{"drugbank":["DB11744"]},"childChemblIds":["CHEMBL3527377","CHEMBL3527376"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707327","drugType":"Antibody","blackBoxWarning":false,"name":"SUPTAVUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-2222","REGN2222","SAR-438584","SAR438584","Suptavumab"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3786098","canonicalSmiles":"C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](OC)C1","inchiKey":"ODMXWZROLKITMS-RISCZKNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06459988","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06459988","Pf-06459988"],"crossReferences":{"drugbank":["DB14768"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3822773","canonicalSmiles":"O=C(O)c1ccc([C@H]2C[C@@H]2c2ccc(OCc3c(-c4c(Cl)cccc4Cl)noc3C3CC3)cc2Cl)cc1","inchiKey":"XBUXXJUEBFDQHD-NHCUHLMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3822773","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15416"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833343","drugType":"Antibody","blackBoxWarning":false,"name":"VOBARILIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-0061","ALX0061","Vobarilizumab"],"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL385178","canonicalSmiles":"O=C(Nc1ccc(Oc2ccccc2)cc1)c1cccnc1NCc1ccncc1","inchiKey":"CPVRYQAOUPSUDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07183"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL388978","canonicalSmiles":"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4","inchiKey":"HKSZLNNOFSGOKW-FYTWVXJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STAUROSPORINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["125299371","134959007","172131318","26755744","26755745"],"drugbank":["DB02010"],"chEBI":["15738"]},"childChemblIds":["CHEMBL3436363"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3899477","canonicalSmiles":"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1nc2c(c(Nc3ccccc3S(=O)(=O)NC(C)C)n1)CCN2","inchiKey":"NPJCURIANJMFEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONTELTINIB ","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Conteltinib "],"linkedTargets":{"rows":["ENSG00000120899","ENSG00000171094","ENSG00000169398","ENSG00000140443"],"count":4},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3977543","canonicalSmiles":"Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12","inchiKey":"KVCQTKNUUQOELD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELVARAFENIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belvarafenib"],"linkedTargets":{"rows":["ENSG00000078061","ENSG00000157764","ENSG00000132155"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL398707","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5","inchiKey":"WVLOADHCBXTIJK-YNHQPCIGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROMORPHONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dilaudid","Dilaudid-HP","Dimorphone","Hydromorphon","Hydromorphone","IDS-NH-004","Jurnista","N02AA03","NSC-19046","Novolaudon","Palladone"],"crossReferences":{"DailyMed":["hydromorphone%20hydrochloride"],"Wikipedia":["Hydromorphone"],"drugbank":["DB00327"],"chEBI":["5790"]},"childChemblIds":["CHEMBL3989585","CHEMBL1237055"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0004240","HP_0012532","Orphanet_232","MONDO_0004567","HP_0003418","EFO_0010702","EFO_0003843","EFO_0000311","HP_0002018","EFO_0000546","MONDO_0005277","HP_0002027","EFO_0003890","MONDO_0021148","EFO_1000786","EFO_1001898","EFO_0001421","EFO_0004616","HP_0003419","EFO_0005611","EFO_0009620","HP_0002019"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and drug dependence and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL398940","canonicalSmiles":"NCCNCCN1CC1","inchiKey":"XJNAQZHMIAKQOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL398940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989507","canonicalSmiles":"O.O.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CC(=O)O.[Na+].[Na+]","inchiKey":"OVBJJZOQPCKUOR-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETATE DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1749","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disodium edetate","Edetate disodium","Endrate","Sodium versenate"],"synonyms":["Chelest f-na","Dinatrii edetas","Disodium edetate","Disodium edta","Disodium edta dihydrate","E-386","Edetate disodium","Edta disodium","Ethylenediaminetetraacetate","Ethylenedinitrilotetraacetate disodium","Ins no.386","Ins-386","Sodium edetate","Titriplex iii"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for eye disease."}
{"id":"CHEMBL3989556","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC.Cl.O","inchiKey":"SPFVHFBNXPARTR-IDMXKUIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMOXIPRIDE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL22242","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hematological toxicity"],"year":1993},"tradeNames":["Roxiam","Roxiam ir"],"synonyms":["(-)-FLA-731","A 33547.HCL.H20","FLA 731(-)","FLA-731","Remoxipride hcl","Remoxipride hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It was withdrawn in United Kingdom  in 1993 due to Hematological toxicity."}
{"id":"CHEMBL3989924","drugType":"Unknown","blackBoxWarning":false,"name":"LUTETIUM DOTATATE LU-177","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991432","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lutathera"],"synonyms":["(177)lu-dotatate","177lu-dota-tyr3-octreotate","177lu-dotatate","Dota-octreotate lutetium lu-177","Dotatate lutenium lu-177","Dotatate lutetium lu-177","Lutetium (177lu) oxodotreotide","Lutetium dotatate lu-177","Lutetium dotatate, lu-177","Lutetium lu 177 dotatate","Lutetium lu-177 dotatate","Lutetium oxodotreotide lu-177","Oxodotreotide lutetium lu-177","Oxodotreotide lutetium, lu-177"],"crossReferences":{"DailyMed":["lutetium%20dotatate%20lu-177"]},"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["MONDO_0002120","EFO_1001901","MONDO_0024503","Orphanet_2495","EFO_0000305","EFO_0000621","EFO_1000045"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neuroendocrine neoplasm and pancreatic neuroendocrine tumor and has 5 investigational indications."}
{"id":"CHEMBL4116008","canonicalSmiles":"CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1","inchiKey":"BGLPECHZZQDNCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERDULATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerdulatinib","PRT-062070","Prt-2070","RVT-502"],"crossReferences":{"drugbank":["DB15499"]},"childChemblIds":["CHEMBL3991929"],"linkedTargets":{"rows":["ENSG00000165025","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0000095","MONDO_0019473","EFO_0004208","MONDO_0018906"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4216467","canonicalSmiles":"CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21","inchiKey":"CEFJVGZHQAGLHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIPRETINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qinlock"],"synonyms":["DCC-2618","Dcc-2618","Ripretinib"],"crossReferences":{"DailyMed":["ripretinib"],"drugbank":["DB14840"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000157404"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_44890"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for neoplasm and gastrointestinal stromal tumor."}
{"id":"CHEMBL4244843","canonicalSmiles":"C=CC(C)(C)OC[C@H]1O[C@H](O[C@@H]2C3=C([C@H](C)COC(C)=O)C[C@H](O)[C@]3(C)/C=C3/[C@@H](COC)CC[C@H]3[C@@H](C)[C@H]2O)[C@H](O)[C@@H](OC(C)=O)[C@@H]1O","inchiKey":"KXTYBXCEQOANSX-WYKQKOHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4244843","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01780"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297329","canonicalSmiles":"C[C@]1(O)C[C@@](N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1","inchiKey":"AIFGVDXMHWGOGJ-DIVCQZSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-117","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAS 117","Tas-117"],"crossReferences":{"drugbank":["DB15054"]},"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297344","canonicalSmiles":"FC(F)(F)Oc1ccc(Nc2ccc3cccc(Cl)c3n2)cc1","inchiKey":"OZOGDCZJYVSUBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABX-464","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-464","ABX464","Abx-464","Abx464","Obefazimod","SPL-464"],"crossReferences":{"drugbank":["DB14828"]},"linkedTargets":{"rows":["ENSG00000136937","ENSG00000114503"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","MONDO_0100096","EFO_0000764","EFO_0000384"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297586","canonicalSmiles":"CN(CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1)C(=O)CNC(=O)CN","inchiKey":"YBZSGIWIPOUSHY-UHFFFAOYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRORILUZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BHV-4157a","Trigriluzole","Troriluzole"],"crossReferences":{"drugbank":["DB15079"]},"childChemblIds":["CHEMBL4297673"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297775","drugType":"Unknown","blackBoxWarning":false,"name":"KAI-1678","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KP-1678","Kai-1678"],"linkedTargets":{"rows":["ENSG00000171132"],"count":1},"linkedDiseases":{"rows":["MONDO_0041052","EFO_1001919","EFO_0003843"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297851","drugType":"Unknown","blackBoxWarning":false,"name":"XMT-1536","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-napi2b adc xmt-1536","XMT-1536","Xmt-1536"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297882","drugType":"Unknown","blackBoxWarning":false,"name":"FIMAPORFIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amphinex","Fimaporfin"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297978","drugType":"Unknown","blackBoxWarning":false,"name":"BTI-410","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTI-410","Bti-410","Hip-2b","Hip2b","Human proislet peptide","Pancreate","Proisletide acetate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4301163","canonicalSmiles":"CCC(=O)NS(=O)(=O)c1ccc(NC(=O)Cc2ccc(Br)c(Oc3cc(Cl)cc(C#N)c3)c2F)c(Cl)c1","inchiKey":"ULTDEARCBRNRGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELSULFAVIRINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elsulfavirine","R-1206"],"crossReferences":{"drugbank":["DB14929"]},"childChemblIds":["CHEMBL4297377"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL435224","canonicalSmiles":"COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(CC(=O)O)CC3)C(=O)N(CC(C)(C)COC(C)=O)c3ccc(Cl)cc32)c1OC","inchiKey":"CMLUGNQVANVZHY-POURPWNDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAPAQUISTAT ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lapaquistat acetate","TAK 475","TAK-475"],"linkedTargets":{"rows":["ENSG00000079459"],"count":1},"linkedDiseases":{"rows":["HP_0003124","MONDO_0021187","MONDO_0005148","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL443732","canonicalSmiles":"NC(N)=NOCC[C@H](N)C(=O)O","inchiKey":"FSBIGDSBMBYOPN-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANAVANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Canavanine","L-Canavanine Sulfate"],"crossReferences":{"PubChem":["11111008","11113636","50104536","50104537","90341177"],"drugbank":["DB01833"],"chEBI":["609827"]},"childChemblIds":["CHEMBL1741898","CHEMBL1551643"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455333","canonicalSmiles":"Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCCCCc1cn(CCNc3c4c(nc5ccccc35)CCCC4)nn1)c1cc(N)ccc21","inchiKey":"NAARZDJZGYBXKL-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455333","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02226"]},"childChemblIds":["CHEMBL540657"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594308","drugType":"Gene","blackBoxWarning":false,"name":"OLVIMULOGENE NANIVACIREPVEC","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GL-ONC1","Gl-onc1","Glv-1h68","Olvimulogene nanivacirepvec"],"description":"Gene drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594447","canonicalSmiles":"CCCNCCOc1cc(F)cc(S(C)(=O)=O)c1","inchiKey":"OSBPYFBXSLJHCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESDOPETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IRL-790","IRL790","Irl790","Mesdopetam"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594562","drugType":"Unknown","blackBoxWarning":false,"name":"ISIS-2503","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 2503","Isis 2503","Isis-2503"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4597193","canonicalSmiles":"Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1","inchiKey":"SSDRNUPMYCFXGM-UYPAYLBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALEMETOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valemetostat"],"childChemblIds":["CHEMBL4594405"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL465","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21","inchiKey":"CYQFCXCEBYINGO-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DRONABINOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dronabinol","Marinol","Syndros"],"synonyms":[".delta.-9-tetrahydrocannabinol",".delta.1-thc",".delta.9-tetrahydrocannabinol",".delta.9-thc","ABBOTT 40566","ABBOTT-40566","Delta-9-tetrahydrocannabinol","Delta-9-thc","Dronabinol","J882F","NSC-134454","QCD 84924","QCD-84924","SP 104","SP-104","Tetrahydrocannabinol","Tetrahydrocannabinols (-)-trans-.delta.9-form"],"crossReferences":{"DailyMed":["dronabinol"],"PubChem":["144206169"],"Wikipedia":["Tetrahydrocannabinol"],"drugbank":["DB00470"],"chEBI":["66964"]},"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","Orphanet_232","EFO_0000555","HP_0000726","EFO_0003778","HP_0002018","EFO_0007191","HP_0100543","EFO_0000289","HP_0002017","EFO_0004616","HP_0012167","MONDO_0004976","HP_0100749","MONDO_0007079","EFO_0004215","EFO_0003782","HP_0012532","EFO_0006911","EFO_0004329","HP_0002039","EFO_0000677","EFO_0000180","HP_0000473","EFO_0001358","EFO_0003843","EFO_0000311","MONDO_0100431","EFO_0003890","EFO_0010282","MONDO_0005301","HP_0003040","EFO_0004895","EFO_0000764","MONDO_0004975","EFO_0005611","EFO_0003918","EFO_0003108","MONDO_0005475"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 28 investigational indications."}
{"id":"CHEMBL4650266","drugType":"Gene","blackBoxWarning":false,"name":"ZEVORCABTAGENE AUTOLEUCEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-053","CT053","Zevorcabtagene autoleucel"],"description":"Gene drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650334","canonicalSmiles":"C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1","inchiKey":"CMLVKUWQFZQPPS-YUNKPMOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALDUMASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aldumastat","G-504572","G504572","GLPG-1972","GLPG1972","Glpg1972","S-201086","S201086"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650718","canonicalSmiles":"N[C@@]1(c2ccccc2Cl)CCC[C@@H](O)C1=O","inchiKey":"CFBVGSWSOJBYGC-ZYHUDNBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYNORKETAMINE, (2R,6R)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650353"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL478629","canonicalSmiles":"c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1","inchiKey":"XHBVYDAKJHETMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORSOMORPHIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dorsomorphin"],"crossReferences":{"PubChem":["124893194","29217627"],"drugbank":["DB08597"],"chEBI":["78510"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802188","drugType":"Antibody","blackBoxWarning":false,"name":"PULOCIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-109","AK109","Ak109","Pulocimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL489657","canonicalSmiles":"Cc1cccc(C)c1C(=O)Nc1cc(Br)c(O)c(Br)c1","inchiKey":"IFECSMFQARKPSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07693"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL50444","canonicalSmiles":"CC(O)(CC(=O)O)CC(=O)O","inchiKey":"NPOAOTPXWNWTSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGLUTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB 337","CB-337","Meglutol","NSC-361411"],"crossReferences":{"Wikipedia":["Meglutol"],"drugbank":["DB04377"],"chEBI":["16831"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL513994","canonicalSmiles":"N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F","inchiKey":"IENZFHBNCRQMNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRX-08066","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297322"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL56564","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2","inchiKey":"ZNRGQMMCGHDTEI-ITGUQSILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPISETRON","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navoban"],"synonyms":["ICS-205-930","NSC-759842","Novaban","SDZ-ICS-930","Tropisetron","Tropisetron (as hydrochloride)","Tropisetron hcl","Tropisetron hydrochloride","Tropisetron monohydrochloride"],"crossReferences":{"PubChem":["26755041"],"drugbank":["DB11699"],"chEBI":["32269"]},"childChemblIds":["CHEMBL3348564","CHEMBL2130744"],"linkedTargets":{"rows":["ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":5},"linkedDiseases":{"rows":["EFO_0006911","HP_0002013","EFO_0009267","EFO_0003843","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for nausea and has 1 investigational indication."}
{"id":"CHEMBL569713","canonicalSmiles":"CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"STECJAGHUSJQJN-FWXGHANASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCOPOLAMINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isoptpo Hyoscine","Scopolamine","Transderm scop"],"synonyms":["Scopolamine"],"crossReferences":{"DailyMed":["scopolamine"],"drugbank":["DB00747"],"chEBI":["16794"]},"childChemblIds":["CHEMBL2251240","CHEMBL3185877","CHEMBL1530287","CHEMBL1877254"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["EFO_0006928","MONDO_0002009","HP_0000726","EFO_1001917","EFO_0003843","HP_0002018","HP_0002027","EFO_1001412","EFO_0000289","MONDO_0002050","EFO_0010282","EFO_0005758","EFO_0000544","EFO_0009431","HP_0002017","MONDO_0004975","EFO_0004888","EFO_1000632","EFO_0003761","HP_0002013","MONDO_0004976","HP_0002307"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 4 approved and 14 investigational indications."}
{"id":"CHEMBL692","canonicalSmiles":"OCC(O)CO","inchiKey":"PEDCQBHIVMGVHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glycerol","Glycogelatin","Keybells","Nirolex","Ophthalgan","Optim","Osmoglyn","Senokot direct relief","Tixylix baby","Tixylix toddler","Waterhouse"],"synonyms":["E-422","E422","FEMA NO. 2525","Glycerin","Glycerin,anhydrous","Glycerinum","Glycerol","Glycerol 85%","Glycerolum","INS NO.422","INS-422","M 314429","Monoctanoin Component D","Monoctanoin component d","NSC-9230","PZN 7474853","Tryhydroxypropane"],"crossReferences":{"DailyMed":["glycerin"],"PubChem":["144204594","144209275","144210464","17388987","17389867","29215106"],"Wikipedia":["Glycerol"],"drugbank":["DB09462"],"chEBI":["17754"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 6 approved and 9 investigational indications."}
{"id":"CHEMBL709","canonicalSmiles":"COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC","inchiKey":"WNMJYKCGWZFFKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFUZOSIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alfuzosin","NSC-760065","Uroxatral"],"crossReferences":{"DailyMed":["alfuzosin%20hydrochloride"],"PubChem":["174007387","26719847","26749009","26749010","50107503","50107504","90341616"],"Wikipedia":["Alfuzosin"],"drugbank":["DB00346"],"chEBI":["51141"]},"childChemblIds":["CHEMBL1723"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_1001412","HP_0000016","MONDO_0005301","EFO_0004253","EFO_1001228","EFO_0000284","EFO_0003830","HP_0000011","HP_0002019"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for benign prostatic hyperplasia and has 7 investigational indications."}
{"id":"CHEMBL73822","canonicalSmiles":"Cn1c(/C=C/CO)c(CO)c2c1C(=O)C=C(N1CC1)C2=O","inchiKey":"MXPOCMVWFLDDLZ-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APAZIQUONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apaziquone","EO-9","EO9","Eoquin","NOR-701","NSC-382456","NSC-382459","Qapzola"],"crossReferences":{"PubChem":["470867"],"Wikipedia":["Apaziquone"],"drugbank":["DB12593"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL8211","canonicalSmiles":"CCN1C(=O)C=CC1=O","inchiKey":"HDFGOPSGAURCEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-ETHYLMALEIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111152","50106270","85231035","90341440"],"Wikipedia":["N-Ethylmaleimide"],"drugbank":["DB02967"],"chEBI":["44485"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93647","canonicalSmiles":"NC(N)=Nc1nc(-c2ccc(CNc3nc4ccccc4[nH]3)s2)cs1","inchiKey":"CKJGKHXCUDWFDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93647","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
